Gene therapy for ovarian cancer - PubMed (original) (raw)

Review

Gene therapy for ovarian cancer

Kristopher J Kimball et al. Curr Oncol Rep. 2006 Nov.

Abstract

Ovarian cancer remains the leading cause of death due to gynecologic cancer in women in the United States. Gene and viral-based therapies represent novel therapeutic approaches for cancer. The manipulation of genetic content of tumor cells toward a therapeutic end has been divided into several general strategies, including molecular chemotherapy, mutation compensation, immunopotentiation, and virotherapy. Improvements in delivery vehicles and in evaluation of gene transfer and viral replication remain important areas of investigation. We highlight the most recent advances in these novel therapeutic approaches for ovarian cancer and include a summary of recent clinical trials.

PubMed Disclaimer

Similar articles

• Targeted gene therapy for ovarian cancer.
  Rocconi RP, Numnum TM, Stoff-Khalili M, Makhija S, Alvarez RD, Curiel DT. Rocconi RP, et al. Curr Gene Ther. 2005 Dec;5(6):643-53. doi: 10.2174/156652305774964668. Curr Gene Ther. 2005. PMID: 16457653 Review.
• Recent Progress in Gene Therapy for Ovarian Cancer.
  Áyen Á, Jiménez Martínez Y, Marchal JA, Boulaiz H. Áyen Á, et al. Int J Mol Sci. 2018 Jun 30;19(7):1930. doi: 10.3390/ijms19071930. Int J Mol Sci. 2018. PMID: 29966369 Free PMC article. Review.
• From gene therapy to virotherapy for ovarian cancer.
  Stoff-Khalili MA, Dall P, Curiel DT. Stoff-Khalili MA, et al. Minerva Ginecol. 2004 Dec;56(6):503-14. Minerva Ginecol. 2004. PMID: 15729203 Review.
• Oncolytic adenoviral gene therapy in ovarian cancer: why we are not wasting our time.
  Young A, McNeish IA. Young A, et al. Future Oncol. 2009 Apr;5(3):339-57. doi: 10.2217/fon.09.11. Future Oncol. 2009. PMID: 19374541 Review.
• Gene therapy: ovarian carcinoma as the paradigm.
  Gómez-Navarro J, Siegal GP, Alvarez RD, Curiel DT. Gómez-Navarro J, et al. Am J Clin Pathol. 1998 Apr;109(4):444-67. doi: 10.1093/ajcp/109.4.444. Am J Clin Pathol. 1998. PMID: 9535399 Review.

Cited by

• Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer.
  Ashshi AM, El-Shemi AG, Dmitriev IP, Kashentseva EA, Curiel DT. Ashshi AM, et al. J Ovarian Res. 2016 Jun 27;9(1):38. doi: 10.1186/s13048-016-0248-5. J Ovarian Res. 2016. PMID: 27349517 Free PMC article.
• Inhibitory effects of the ultrasound-targeted microbubble destruction-mediated herpes simplex virus-thymidine kinase/ganciclovir system on ovarian cancer in mice.
  Zhou XL, Shi YL, Li X. Zhou XL, et al. Exp Ther Med. 2014 Oct;8(4):1159-1163. doi: 10.3892/etm.2014.1877. Epub 2014 Aug 4. Exp Ther Med. 2014. PMID: 25187815 Free PMC article.
• Targeting estrogen-related receptor alpha inhibits epithelial-to-mesenchymal transition and stem cell properties of ovarian cancer cells.
  Lam SS, Mak AS, Yam JW, Cheung AN, Ngan HY, Wong AS. Lam SS, et al. Mol Ther. 2014 Apr;22(4):743-51. doi: 10.1038/mt.2014.1. Epub 2014 Jan 14. Mol Ther. 2014. PMID: 24419103 Free PMC article.
• A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer.
  Kim KH, Dmitriev IP, Saddekni S, Kashentseva EA, Harris RD, Aurigemma R, Bae S, Singh KP, Siegal GP, Curiel DT, Alvarez RD. Kim KH, et al. Gynecol Oncol. 2013 Sep;130(3):518-24. doi: 10.1016/j.ygyno.2013.06.003. Epub 2013 Jun 10. Gynecol Oncol. 2013. PMID: 23756180 Free PMC article. Clinical Trial.
• Targeting gonadotropin-releasing hormone receptor inhibits the early step of ovarian cancer metastasis by modulating tumor-mesothelial adhesion.
  Cheung LW, Yung S, Chan TM, Leung PC, Wong AS. Cheung LW, et al. Mol Ther. 2013 Jan;21(1):78-90. doi: 10.1038/mt.2012.187. Epub 2012 Nov 20. Mol Ther. 2013. PMID: 23164934 Free PMC article.

References

1. 1. Mol Ther. 2006 Aug;14(2):164-74 - PubMed
2. 1. Gene Ther. 2005 Dec;12(23):1696-706 - PubMed
3. 1. Cancer Res. 2002 Mar 1;62(5):1266-70 - PubMed
4. 1. J Virol. 1996 Oct;70(10):6839-46 - PubMed
5. 1. Cancer Res. 2005 Sep 15;65(18):8406-13 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information